{
    "nctId": "NCT00002762",
    "briefTitle": "Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer",
    "officialTitle": "MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Perioperative/Postoperative Complications",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1118,
    "primaryOutcomeMeasure": "disease-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women age 18 to 55 years\n2. Regular menstrual cycles of 21- to 35-days duration\n3. Pathologic stages I to II breast cancer, in whom all gross disease-including ductal carcinoma in situ-was surgically removed either in a one-stage or two-stage procedure.\n4. required serum be drawn within 1 calendar day of the lumpectomy/mastectomy for women who underwent a one-stage procedure and within 1 calendar day of each stage for women who underwent a two-stage procedure.\n\nExclusion Criteria:\n\n1. Lactation within the past 3 months\n2. galactorrhea\n3. neoadjuvant therapy\n4. previous breast cancer, and history of any cancer (except squamous or basal cell skin carcinoma) in which the patient was not disease-free for at least 10 years",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}